Thursday, May 6, 2021
wellness India Expo
Home Tags Tuberculosis

Tag: Tuberculosis

Vital Strategies releases public education resources to accelerate govt’s END TB...

On World TB Day, Vital Strategies has released two new communication resources to support the Government of India’s effort to END TB once and for all.........................

Dr Harsh Vardhan appointed as Chairman of ‘Stop TB Partnership Board’

Established in the year 2000, the ‘Stop TB Partnership’ is mandated to eliminate Tuberculosis as a public health problem.....................

FIND & India Health Fund to help expand access to Covid-19...

To expand rapid, onsite Covid-19 confirmatory testing for symptomatic people who test negative to rapid antigen tests, and facilitate tuberculosis screening of people with Covid-19 symptoms, FIND and IHF are deploying five.....................

COVID-19 shouldn’t deter us from goal to eliminate TB by 2025,...

Setting the way forward, Dr Harsh Vardhan met Development Partners to discuss the challenge and opportunity in eradicating Tuberculosis by the year 2025.........................

Scientists devise frugal method to extract anti-TB agents from marine microalgae

The marine natural compounds isolated from the microalgae using a cost-effective method by the NIOT scientists would contribute to the development of a new compound to kill the dormant tuberculosis bacteria......................

TB a priority despite COVID-19: Dr Harsh Vardhan

Dr Harsh Vardhan, Union Minister of Health and Family Welfare has stated that the Government is committed to scaling up access to free diagnosis through rapid molecular tests, provide information on drug resistance, and also a free treatment for all people with TB with best-quality drugs.....................

First synthethic path for tuberculosis & chikungunya inhibiting flavonoid molecules deciphered

Scientists from Agharkar Research Institute (ARI), Pune, an autonomous institute of the Department of Science and Technology (DST), Govt. of India, have come up with the first synthetic route for producing flavonoids molecules related to the treatment of tuberculosis and chikungunya......................

Lupin launches Favipiravir drug, Covihalt for treatment of mild to moderate...

Lupin Limited has announced the launch of its Favipiravir in India under the brand name Covihalt® for the treatment of mild to moderate COVID-19...................

“Our unique doorstep delivery model goes beyond health”

In an exclusive Chat with BioVoice, Mr Sandeep Ahuja, the CEO and Co-founder of Operation ASHA shared details about how a highly cost-effective, resource-efficient, and patient-centric model developed by him have also been replicated in seven other countries....................

Mylan secures DCGI approval for its drug-resistant TB drug, Pretomanid

Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be approved in more than 40 years. The approval comes as a result of Mylan’s global collaboration with non-profit drug development partner TB Alliance..................